INVESTIGADORES
AMARAL Maria Marta
congresos y reuniones científicas
Título:
Partial Purification of ADAMTS-13
Autor/es:
POWAZNIAK, YANINA; KEMPFER ANA C; AMARAL MARÍA M; FARÍAS, CRISTINA; VERA, EZEQUIEL; LAZZARI MARÍA A
Lugar:
Sydney
Reunión:
Congreso; XX CONGRESS. THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS AND 51st ANNUAL SSC METTING; 2005
Institución organizadora:
THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS
Resumen:
We developed the partial purification (P) of ADAMTS-13 by methods (M) in which
cryoprecipitates were prepared from: M1- plasma, M2- plasma treated with
polyetilenglicol (PEG) 4% (known M) and M3- supernatant obtained from M1 treated
with PEG 4%, M4- dialyzed precipitate (dissolved in saline) obtained from M2 (combined
M). Assays: VWF:Ag , ADAMTS-13, fibrinogen (Fg) (100U/dL= 390 mg/dL assayed by
Clauss M), proteins. P was expressed as specific activity (SA) of samples (U/g of protein)/
/SA of the original plasma (14 U/g). P results (mean ±SD, n=5) of precipitate (p) and
supernatant (s) fractions (Fr) obtained by centrifugation from M1 to M4 are in the Table.
Fr ADAMTS-13 VWF:Ag ADAMTS-13/VWF:Ag Fg ADAMTS-13/Fg
1p 1,4 ±0,6 45±20 0.03 23±10 0.06
1s 1.5±0.8 0,2±0,1 7.50* 0,4±0.2 3.75*
2p 11±5 * 20±10 0.55 17±12 0.65
2s 1,0±0.3 0,4±0,2 2.50* 0,6±0,4 1.67
3p 7±4 * 4±2 1.75* 3.5±0.7 2.00*
3s 1.5±0,5 0,3±0,2 5.00* 0.6±0.3 2.67*
4p 16±8* 33±18 0.48 16±12 1.00
4s 6±2* 3±2 2.00* 13±3 0.50
The Fr 3p fulfills the three requirements (adequate P and not so high contamination of
VWF:Ag and Fg) considering 1.75 (with asterisk) as cut-off level. This Fr could be used
like source to purify ADAMTS-13. Treatment options for thrombotic thrombocytopenic
purpura include fresh frozen plasma infusion. Aronson D (VS 2003), assaying Cohn Fr,
suggested that the use of partially purified Fr may be particularly valuable in lowering
the volume administeredand decreasing the risk of allergic reactions. The therapeutic
use of these new Fr from combined M must be investigated.